Correlation Between Abcellera Biologics and Fast Retailing

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Fast Retailing at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Fast Retailing into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Fast Retailing Co, you can compare the effects of market volatilities on Abcellera Biologics and Fast Retailing and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Fast Retailing. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Fast Retailing.

Diversification Opportunities for Abcellera Biologics and Fast Retailing

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Abcellera and Fast is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Fast Retailing Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fast Retailing and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Fast Retailing. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fast Retailing has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Fast Retailing go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Fast Retailing

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 2.06 times more return on investment than Fast Retailing. However, Abcellera Biologics is 2.06 times more volatile than Fast Retailing Co. It trades about 0.03 of its potential returns per unit of risk. Fast Retailing Co is currently generating about 0.05 per unit of risk. If you would invest  292.00  in Abcellera Biologics on September 14, 2024 and sell it today you would earn a total of  3.00  from holding Abcellera Biologics or generate 1.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Abcellera Biologics  vs.  Fast Retailing Co

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Fast Retailing 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Fast Retailing Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Fast Retailing is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Abcellera Biologics and Fast Retailing Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and Fast Retailing

The main advantage of trading using opposite Abcellera Biologics and Fast Retailing positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Fast Retailing can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fast Retailing will offset losses from the drop in Fast Retailing's long position.
The idea behind Abcellera Biologics and Fast Retailing Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets